Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
The first meta-analysis to examine hep C treatment outcomes in seniors versus non-seniors found that cure rates are comparable.
The American Association for the Study of Liver Diseases has updated the treatment guidelines for hepatitis C.
This marks a 15-fold increase for liver disease drugs since new HCV therapies started rolling out in 2013.
While highly expensive, treating hepatitis C with the combination of Sovaldi and Olysio is still cheaper per cure than treating with interfer...
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.